Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-368,848
Closed -$31M 169
2025
Q3
$31M Buy
368,848
+277,916
+306% +$22.9M 1.72% 22
2025
Q2
$7.2M Buy
90,932
+205
+0.2% +$16.3K 0.32% 48
2025
Q1
$8.14M Buy
90,727
+18,055
+25% +$1.69M 0.31% 51
2024
Q4
$7.23M Buy
+72,672
New +$7.49M 0.26% 52
2017
Q4
Sell
-12,502
Closed -$764K 76
2017
Q3
$764K Sell
12,502
-4,983
-28% -$302K 0.03% 59
2017
Q2
$1.07M Sell
17,485
-108
-0.6% -$6.57K 0.05% 48
2017
Q1
$1.07M Sell
17,593
-118
-0.7% -$7.16K 0.06% 44
2016
Q4
$1M Sell
17,711
-315
-2% -$18.4K 0.06% 55
2016
Q3
$1.06M Buy
18,026
+1,431
+9% +$83.7K 0.06% 56
2016
Q2
$912K Sell
16,595
-859
-5% -$45.7K 0.04% 64
2016
Q1
$881K Sell
17,454
-619
-3% -$30.3K 0.04% 67
2015
Q4
$911K Sell
18,073
-18,348
-50% -$925K 0.04% 71
2015
Q3
$1.72M Sell
36,421
-4,102
-10% -$218K 0.07% 59
2015
Q2
$2.2M Sell
40,523
-8,233
-17% -$462K 0.1% 49
2015
Q1
$2.67M Sell
48,756
-15,430
-24% -$874K 0.12% 46
2014
Q4
$3.48M Sell
64,186
-409
-0.6% -$22.8K 0.11% 39
2014
Q3
$3.65M Sell
64,595
-1,027
-2% -$57.7K 0.13% 37
2014
Q2
$3.65M Sell
65,622
-8,970
-12% -$489K 0.12% 40
2014
Q1
$4.04M Sell
74,592
-1,756
-2% -$90.9K 0.12% 35
2013
Q4
$3.64M Sell
76,348
-963,904
-93% -$44.1M 0.13% 30
2013
Q3
$47.6M Sell
1,040,252
-28,619
-3% -$1.31M 2.21% 12
2013
Q2
$47.4M Buy
+1,068,871
New +$47.7M 2.55% 13

Other funds holding MRK

Ruffer LLP's MRK Position: Q4 2025 in Review

Ruffer LLP sold out of Merck (MRK) in Q4 2025, closing a stake of 368,848 shares — an estimated $31M sold.

Ruffer LLP first reported a position in MRK in Q2 2013 and held it in 22 quarters. The position peaked at $47.6M in Q3 2013. 3,652 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Ruffer LLP reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Ruffer LLP sold 368,848 Merck shares in Q4 2025, an estimated $31M.
  • Ruffer LLP first reported a position in Merck in Q2 2013 and held it in 22 quarters.
  • Ruffer LLP's Merck position peaked at $47.6M in Q3 2013.
  • 3,652 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Ruffer LLP's 13F filing for Q4 2025, filed 28 Jan 2026.